NCT06123117Recruiting
STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy
Single Transversus Abdominis Laparoscopy-guided Plane Block Combined With Local Trocar Site Ropivacaine Infiltration (STALL) vs Sole Local Wound Infiltration in LCC (Laparoscopic CholeCystectomy) - Double-blinded Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
This trial is a prospective randomized superiority trial comparing sole ropivacaine based local trocar site infiltration to local infiltration combined with laparoscopic ropivacaine TAP block (STALL) in LCC. There are only a few randomized trials comparing sole local anesthesia to additional laparoscopic TAP block in laparoscopic cholecystectomy and they have yet failed to show evidence in favor of TAP block. We hypothesize STALL (Single Transversus Abdominis Laparoscopy-guided plane block combined with Local trocar site ropivacaine infiltration) is superior to local port site infiltration, provided that the sample size is sufficiently big. The aim of this randomized study is to compare the efficacy of sole local anesthesia of trocar sites to STALL in LCC.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 850 (estimated)
- First submitted
- 5 Nov 2023
- Start date
- 16 Jan 2024
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Helsinki University Central Hospital
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06123117
What you commit to
- Study type: Interventional
- Planned participants: 850
- From 16 Jan 2024 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age under 18 years, chronic daily opioid and/or pain tolerance / pain threshold -modifying medication use (abuse), pregnancy, known allergy to local anesthetics, diagnosed severe coagulopathy and incapability to give informed consent for whatever reason.
Who the study is looking for
- All patients scheduled for elective or emergency LCC, aged over 18 and able to give an informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Jorvi hospital / HUS Coordinator of this site? Confirm its status | Espoo | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.